Literature DB >> 2017817

Treatment of female incontinence secondary to urethral damage or loss.

J G Blaivas1.   

Abstract

Damage to the urethra may be functional or anatomic. In the former, to some extent, the urethra functions merely as a tube. Anatomic damage ranges from small urethrovaginal fistulas to total loss of the urethra, vesical neck, and trigone. For functional damage, the goal is compression of the proximal urethra, and the author favors a pubovaginal fascial sling, which is described. In the author's view, the best results in anatomic loss are obtained by performing an appropriate anti-incontinence procedure at the time of urethral reconstruction.

Entities:  

Mesh:

Year:  1991        PMID: 2017817

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  5 in total

1.  Primary slings for everyone with genuine stress incontinence? The argument for...

Authors:  R A Appell
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1998

2.  The use of bone anchoring in the surgical management of female stress urinary incontinence.

Authors:  R A Appell
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

3.  Minimum 1-year results of mesh spiral-sling procedure in managing refractory and primary disabling stress urinary incontinence.

Authors:  Sinasi Yavuz Önol; Osman Sevket; Fikret Fatih Önol; Remzi Erdem; Abdülkadir Tepeler
Journal:  Int Urogynecol J       Date:  2014-08-19       Impact factor: 2.894

4.  Our experience with salvage genitourinary fistulae repair: technique and outcomes.

Authors:  Demetrios K Radopoulos; Georgios P Dimitriadis; Ioannis K Vakalopoulos; Stavros S Ioannidis; Konstantinos A Tzakas; Ioannis E Vasilakakis
Journal:  Int Urol Nephrol       Date:  2007-07-03       Impact factor: 2.370

5.  Outcome of female urethral reconstruction: a 12-year experience.

Authors:  M H Radwan; M O Abou Farha; M G Soliman; M El Refai; M M Ragab; A M Shaaban; O M Abou Farha
Journal:  World J Urol       Date:  2013-04-30       Impact factor: 4.226

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.